Lena W Y Thin1,2,3, Sherman Picardo4, Shanela Sooben5, Kevin Murray6, Jennifer Ryan7, Marina H Wallace8,7. 1. Department of Gastroenterology, Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch, Perth, Western Australia, 6150, Australia. Lena.thin@health.wa.gov.au. 2. Level 1, Harry Perkins Institute of Medical Research, 11 Robin Warren Drive, Murdoch, Perth, Western Australia, 6510, Australia. Lena.thin@health.wa.gov.au. 3. School of Medicine and Pharmacology, University of Western Australia, 35 Stirling Highway, Perth, Western Australia, 6150, Australia. Lena.thin@health.wa.gov.au. 4. Department of Gastroenterology, Royal Perth Hospital, 197 Wellington St, Perth, WA, 6000, Australia. 5. Department of Gastroenterology, Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch, Perth, Western Australia, 6150, Australia. 6. School of Population Health, University of Western Australia, 35 Stirling Highway, Perth, Western Australia, 6000, Australia. 7. Department of Colorectal Surgery, Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch, Perth, Western Australia, 6150, Australia. 8. School of Medicine and Pharmacology, University of Western Australia, 35 Stirling Highway, Perth, Western Australia, 6150, Australia.
Abstract
BACKGROUND AND AIM: Several risk factors affecting post-operative recurrence in Crohn's disease patients have been studied, and of these, the role of the anastomosis remains contentious. We aimed to compare the risk of developing early post-operative endoscopic recurrence (EPER), in resections that had an end-to-end anastomosis (ETEA) to a side-to-side anastomosis (STSA). METHODS: All Crohn's disease patients that underwent an ileocolic or small bowel resection between January 2012 and June 2017 at two tertiary IBD centres were reviewed retrospectively. Included patients had a minimum of 12-month clinical follow-up and a colonoscopy within 12 months of the resection or stoma reversal. Univariate and multivariate binary logistic regression analyses determined the independent risk factors for early post-operative endoscopic recurrence, defined as a Rutgeerts score of ≥ i2b. RESULTS: Ninety-two resections associated with an ETEA or a STSA were included for analysis. The ETEA was the most common anastomosis, constructed in 55 patients (59.8%). Forty-nine operations (53.3%) resulted in a ≥ i2b recurrence at the first surveillance colonoscopy. The multivariate analysis showed that there was no difference between the ETEA and STSA in determining the odds ratio (OR) for developing EPER (OR = 2.41 (0.95-6.05), P = 0.06). In those that underwent a resection emergently however, the significant determinants of EPER were as follows: having an ETEA (OR = 38.12 (2.44-595.87), P = 0.01), failing to commence a biologic and/or an immunosuppressant early (OR = 24.21 (1.69, 347.81), P = 0.02), and active smoking (OR = 7.19 (1.12-46.21), P = 0.04). CONCLUSION: The ETEA is best avoided in those undergoing an emergency resection. The early commencement of a biologic and/or an immunosuppressant and smoking cessation is imperative this high-risk group of patients.
BACKGROUND AND AIM: Several risk factors affecting post-operative recurrence in Crohn's diseasepatients have been studied, and of these, the role of the anastomosis remains contentious. We aimed to compare the risk of developing early post-operative endoscopic recurrence (EPER), in resections that had an end-to-end anastomosis (ETEA) to a side-to-side anastomosis (STSA). METHODS: All Crohn's diseasepatients that underwent an ileocolic or small bowel resection between January 2012 and June 2017 at two tertiary IBD centres were reviewed retrospectively. Included patients had a minimum of 12-month clinical follow-up and a colonoscopy within 12 months of the resection or stoma reversal. Univariate and multivariate binary logistic regression analyses determined the independent risk factors for early post-operative endoscopic recurrence, defined as a Rutgeerts score of ≥ i2b. RESULTS: Ninety-two resections associated with an ETEA or a STSA were included for analysis. The ETEA was the most common anastomosis, constructed in 55 patients (59.8%). Forty-nine operations (53.3%) resulted in a ≥ i2b recurrence at the first surveillance colonoscopy. The multivariate analysis showed that there was no difference between the ETEA and STSA in determining the odds ratio (OR) for developing EPER (OR = 2.41 (0.95-6.05), P = 0.06). In those that underwent a resection emergently however, the significant determinants of EPER were as follows: having an ETEA (OR = 38.12 (2.44-595.87), P = 0.01), failing to commence a biologic and/or an immunosuppressant early (OR = 24.21 (1.69, 347.81), P = 0.02), and active smoking (OR = 7.19 (1.12-46.21), P = 0.04). CONCLUSION: The ETEA is best avoided in those undergoing an emergency resection. The early commencement of a biologic and/or an immunosuppressant and smoking cessation is imperative this high-risk group of patients.
Authors: Gert Van Assche; Axel Dignass; Walter Reinisch; C Janneke van der Woude; Andreas Sturm; Martine De Vos; Mario Guslandi; Bas Oldenburg; Iris Dotan; Philippe Marteau; Alessandro Ardizzone; Daniel C Baumgart; Geert D'Haens; Paolo Gionchetti; Francisco Portela; Boris Vucelic; Johan Söderholm; Johanna Escher; Sibylle Koletzko; Kaija-Leena Kolho; Milan Lukas; Christian Mottet; Herbert Tilg; Séverine Vermeire; Frank Carbonnel; Andrew Cole; Gottfried Novacek; Max Reinshagen; Epameinondas Tsianos; Klaus Herrlinger; Bas Oldenburg; Yoram Bouhnik; Ralf Kiesslich; Eduard Stange; Simon Travis; James Lindsay Journal: J Crohns Colitis Date: 2009-12-21 Impact factor: 9.071
Authors: Peter De Cruz; Michael A Kamm; Lani Prideaux; Patrick B Allen; Paul V Desmond Journal: Inflamm Bowel Dis Date: 2011-08-09 Impact factor: 5.325
Authors: Peter De Cruz; Michael A Kamm; Amy L Hamilton; Kathryn J Ritchie; Efrosinia O Krejany; Alexandra Gorelik; Danny Liew; Lani Prideaux; Ian C Lawrance; Jane M Andrews; Peter A Bampton; Peter R Gibson; Miles Sparrow; Rupert W Leong; Timothy H Florin; Richard B Gearry; Graham Radford-Smith; Finlay A Macrae; Henry Debinski; Warwick Selby; Ian Kronborg; Michael J Johnston; Rodney Woods; P Ross Elliott; Sally J Bell; Steven J Brown; William R Connell; Paul V Desmond Journal: Lancet Date: 2014-12-24 Impact factor: 79.321
Authors: I F de Barcelos; P G Kotze; A Spinelli; Y Suzuki; F V Teixeira; I C de Albuquerque; R Saad-Hossne; L M da Silva Kotze; T Yamamoto Journal: Colorectal Dis Date: 2017-01 Impact factor: 3.788
Authors: Paolo Gionchetti; Axel Dignass; Silvio Danese; Fernando José Magro Dias; Gerhard Rogler; Péter Laszlo Lakatos; Michel Adamina; Sandro Ardizzone; Christianne J Buskens; Shaji Sebastian; Silvio Laureti; Gianluca M Sampietro; Boris Vucelic; C Janneke van der Woude; Manuel Barreiro-de Acosta; Christian Maaser; Francisco Portela; Stephan R Vavricka; Fernando Gomollón Journal: J Crohns Colitis Date: 2016-09-22 Impact factor: 10.020